High expression of CXCR-2 correlates with lymph node metastasis and predicts unfavorable prognosis in resected esophageal carcinoma

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Medical Oncology

• Publication date

  2014-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s12032-013-0809-zPMID 24338377
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• CXCR2: a target for pancreatic cancer treatment?

  2013cited by this paper
• Corrigendum to “The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer” [Biochim. Biophys. Acta 1825 (2012) 117–129]

  2013cited by this paper
• Cancer statistics, 2013

  2013cited by this paper
• The expression of chemokine receptors CCR6, CXCR2 and CXCR4 is not organ‐specific for distant metastasis in colorectal cancer: a comparative study

  2013cited by this paper
• Current status of chemokine receptor inhibitors in development.

  2012cited by this paper
• High expression of CXCR2 is associated with tumorigenesis, progression, and prognosis of laryngeal squamous cell carcinoma

  2012cited by this paper
• The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer.

  2012cited by this paper
• Inhibition of CXCLs/CXCR2 axis in the tumor microenvironment might be a potent therapeutics for pancreatic cancer

  2012cited by this paper
• Chemokines as targets for therapy.

  2011cited by this paper
• Chemokines in health and disease.

  2011cited by this paper
• Chemokine research moves on.

  2011cited by this paper
• Chemokines as mediators of tumor angiogenesis and neovascularization.

  2011cited by this paper
• Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases.

  2011cited by this paper
• Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer.

  2011cited by this paper
• Snail Promotes CXCR2 LigandDependent Tumor Progression in NonSmall Cell Lung Carcinoma

  2009cited by this paper
• A Key Role for Early Growth Response-1 and Nuclear Factor-κB in Mediating and Maintaining GRO/CXCR2 Proliferative Signaling in Esophageal Cancer

  2009cited by this paper
• Small-Molecule Antagonists for CXCR2 and CXCR1 Inhibit Human Melanoma Growth by Decreasing Tumor Cell Proliferation, Survival, and Angiogenesis

  2009cited by this paper
• The role of CXC chemokines and their receptors in cancer.

  2008cited by this paper
• A growth-related oncogene/CXC chemokine receptor 2 autocrine loop contributes to cellular proliferation in esophageal cancer.

  2006cited by this paper
• Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis.

  2006cited by this paper
• Arrestin Regulates MAPK Activation and Prevents NADPH Oxidase-dependent Death of Cells Expressing CXCR2*

  2004cited by this paper

• Antioxidant Senotherapy by Natural Compounds: A Beneficial Partner in Cancer Treatment

  2025cites this paper
• Molecular basis of promiscuous chemokine binding and structural mimicry at the C-X-C chemokine receptor, CXCR2.

  2025cites this paper
• CXCL2: a key player in the tumor microenvironment and inflammatory diseases

  2025cites this paper
• The CXCR2 chemokine receptor: A new target for gastric cancer therapy.

  2024cites this paper
• Sex differences in survival following surgery for esophageal cancer: A systematic review and meta-analysis.

  2024cites this paper
• Neutrophils' dual role in cancer: from tumor progression to immunotherapeutic potential.

  2024cites this paper
• Combined Inhibition of Indolamine-2,3-Dioxygenase 1 and C-X-C Chemokine Receptor Type 2 Exerts Antitumor Effects in a Preclinical Model of Cervical Cancer

  2023cites this paper
• Transcriptomic analysis reveals the promotion of lymph node metastasis by Helicobacter pylori infection via upregulating chemokine (C-X-C motif) receptor 2 expression in gastric carcinoma

  2022cites this paper
• CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer

  2022cites this paper
• Endometrial Cancer-Adjacent Tissues Express Higher Levels of Cancer-Promoting Genes than the Matched Tumors

  2022cites this paper
• Contrast-enhanced CT radiomics features to predict recurrence of locally advanced oesophageal squamous cell cancer within 2 years after trimodal therapy

  2021cites this paper
• Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy

  2021cites this paper
• CXCL5/CXCR2 axis in tumor microenvironment as potential diagnostic biomarker and therapeutic target

  2020cites this paper
• CT radiomic features for predicting resectability of oesophageal squamous cell carcinoma as given by feature analysis: a case control study

  2019cites this paper
• Prognostic significance of higher CXCR 2 expression in digestive system cancers : a systematic review and meta-analysis

  2019influential citation
• Chemokines and their receptors as biomarkers in esophageal cancer

  2019cites this paper
• Cancer-Derived VEGF-C Increases Chemokine Production in Lymphatic Endothelial Cells to Promote CXCR2-Dependent Cancer Invasion and MDSC Recruitment

  2019cites this paper
• Etude des mécanismes impliqués dans la reprogrammation de cellules cancéreuses non-souches en cellules souches cancéreuses induite par les radiations ionisantes dans le cancer du sein

  2018cites this paper
• Neutrophils in primary gastric tumors are correlated with neutrophil infiltration in tumor-draining lymph nodes and the systemic inflammatory response

  2018cites this paper
• CXCL8 derived from tumor-associated macrophages and esophageal squamous cell carcinomas contributes to tumor progression by promoting migration and invasion of cancer cells

  2017cites this paper
• A novel cytokine profile associated with cancer metastasis to mediastinal and hilar lymph nodes identified using fine needle aspiration biopsy – A pilot study

  2017cites this paper
• Systematic review and meta-analysis of the prognostic value of CXCR2 in solid tumor patients

  2017cites this paper
• Overexpression of CXCR2 predicts poor prognosis in patients with colorectal cancer

  2017cites this paper
• Cytokine Regulation of Metastasis and Tumorigenicity.

  2016cites this paper
• Serum concentrations of receptor for interleukin 8 in patients with esophageal cancer.

  2016cites this paper
• miR-940 Suppresses Tumor Cell Invasion and Migration via Regulation of CXCR2 in Hepatocellular Carcinoma

  2016cites this paper
• Not easy to become a tumor marker.

  2016cites this paper
• Down-regulation of CXCL 12 by hypermethylation induces cell proliferation , growth and invasion in triple-negative breast cancer

  2016cites this paper
• VEGF-C and VEGF-D expression and its correlation with lymph node metastasis in esophageal squamous cell cancer tissue.

  2015cites this paper
• The prognostic value of CXC chemokine receptor 2 (CXCR2) in cancers: a meta-analysis

  2015influential citation
• Chemokines and their receptors in esophageal cancer—the systematic review and future perspectives

  2015cites this paper
• CXCR2–CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma

  2015cites this paper
• The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients

  2015cites this paper
• The Role of Chemoattractant Receptors in Shaping the Tumor Microenvironment

  2014cites this paper
• Impact of the Prolymphangiogenic Crosstalk in the Tumor Microenvironment on Lymphatic Cancer Metastasis

  2014cites this paper
• CXCL12 chemokine expression suppresses human breast cancer growth and metastasis in vitro and in vivo.

  2014cites this paper